Oxigene Inc (NASDAQ:OXGN)

CAPS Rating: 3 out of 5

A biotechnology company developing novel small-molecule therapeutics to treat cancer and eye diseases.

Recs

0
Player Avatar pchop123 (79.43) Submitted: 12/31/2012 9:35:57 AM : Outperform Start Price: $5.30 OXGN Score: -21.44

this is a CAPS only pick for a short term gain

Featured Broker Partners


Advertisement